Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer

Mostrar otras versiones (1)

The optimal treatment paradigm for patients with oligometastatic non-small cell lung cancer (NSCLC) remains unclear. Some patients with oligometastatic disease experience prolonged remission after locally consolidative radiation therapy (RT), while others harbor micrometastatic disease (below limits...

Descripción completa

Detalles Bibliográficos
Autores principales: Semenkovich, Nicholas P., Badiyan, Shahed N., Samson, Pamela P., Stowe, Hayley B., Wang, Yun E., Star, Rachel, Devarakonda, Siddhartha, Govindan, Ramaswamy, Waqar, Saiama N., Robinson, Clifford G., Vlacich, Gregory, Pellini, Bruna, Chaudhuri, Aadel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545784/
https://www.ncbi.nlm.nih.gov/pubmed/37783809
http://dx.doi.org/10.1038/s41698-023-00440-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545784/
https://www.ncbi.nlm.nih.gov/pubmed/37783809
http://dx.doi.org/10.1038/s41698-023-00440-6

Ejemplares similares